Tubilux Pharma

Tubilux Pharma is a specialized Contract Development and Manufacturing Organization (CDMO) focused exclusively on the ophthalmic sector. Based in Pomezia, Italy, the company provides end-to-end services ranging from formulation development and clinical trial material production to full-scale commercial manufacturing of sterile eye drops, gels, and ointments. With over 80 years of history, Tubilux operates state-of-the-art GMP-certified facilities and serves a global clientele of pharmaceutical and biotech companies. In 2024, the company was acquired by the Théa Group, further strengthening its position in the international eye care market through its expertise in preservative-free and Blow-Fill-Seal technologies.